Protective effect and mechanism of fucoidan on intestinal mucosal barrier function in NOD mice

References

• Abdel-Moneim, A., Bakery, H. H., & Allam, G. (2018). The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus. Biomedicine & Pharmacotherapy, 101, 287–292. https://doi.org/10.1016/j.biopha.2018.02.103
   PubMed Web of Science ®Google Scholar
• Anderson, J. M., & Van Itallie, C. M. (1995). Tight junctions and the molecular basis for regulation of paracellular permeability. American Journal of Physiology, 269, G467–G475. https://doi.org/10.1152/ajpgi.1995.269.4.g467
   PubMed Web of Science ®Google Scholar
• Bachmann, M. F., & Oxenius, A. (2007). Interleukin 2: From immunostimulation to immunoregulation and back again. EMBO Reports, 8(12), 1142–1148. https://doi.org/10.1038/sj.embor.7401099
   PubMed Web of Science ®Google Scholar
• Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008). Induction and effector functions of T(H)17 cells. Nature, 453(7198), 1051–1057. https://doi.org/10.1038/nature07036
   PubMed Web of Science ®Google Scholar
• Bosi, E., Molteni, L., Radaelli, M. G., Folini, L., Fermo, I., Bazzigaluppi, E., Piemonti, L., Pastore, M. R., & Paroni, R. (2006). Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia, 49(12), 2824–2827. https://doi.org/10.1007/s00125-006-0465-3
   PubMed Web of Science ®Google Scholar
• Cardoso, S. M., Pereira, O. R., Seca, A. M., Pinto, D. C., & Silva, A. M. (2015). Seaweeds as preventive agents for cardiovascular diseases: From nutrients to functional foods. Marine Drugs, 13(11), 6838–6865. https://doi.org/10.3390/md13116838
   PubMed Web of Science ®Google Scholar
• Chatzigeorgiou, A., Harokopos, V., Mylona-Karagianni, C., Tsouvalas, E., Aidinis, V., & Kamper, E. F. (2010). The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Annals of Medicine, 42(6), 426–438. https://doi.org/10.3109/07853890.2010.495951
   PubMed Web of Science ®Google Scholar
• Chen, J., Wang, W., Zhang, Q., Li, F., Lei, T., Luo, D., Zhou, H., Yang, B., & Câmara, N. O. S. (2013). Low molecular weight fucoidan against renal ischemia-reperfusion injury via inhibition of the MAPK signaling pathway. PLoS One, 8(2), e56224. https://doi.org/10.1371/journal.pone.0056224
   PubMed Web of Science ®Google Scholar
• Cheng, Y., Sibusiso, L., Hou, L., Jiang, H., Chen, P., Zhang, X., Wu, M., & Tong, H. (2019). Sargassum fusiforme fucoidan modifies the gut microbiota during alleviation of streptozotocin-induced hyperglycemia in mice. International Journal of Biological Macromolecules, 131, 1162–1170. https://doi.org/10.1016/j.ijbiomac.2019.04.040
   PubMed Web of Science ®Google Scholar
• Cui, W., Zheng, Y., Zhang, Q., Wang, J., Wang, L., Yang, W., Guo, C., Gao, W., Wang, X., & Luo, D. (2014). Low-molecular-weight fucoidan protects endothelial function and ameliorates basal hypertension in diabetic Goto-Kakizaki rats. Laboratory Investigation, 94(4), 382–393. https://doi.org/10.1038/labinvest.2014.12
   PubMed Web of Science ®Google Scholar
• Cumashi, A., Ushakova, N. A., Preobrazhenskaya, M. E., D'Incecco, A., Piccoli, A., Totani, L., Tinari, N., Morozevich, G. E., Berman, A. E., Bilan, M. I., Usov, A. I., Ustyuzhanina, N. E., Grachev, A. A., Sanderson, C. J., Kelly, M., Rabinovich, G. A., Iacobelli, S., & Nifantiev, N. E. (2007). A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology, 17(5), 541–552. https://doi.org/10.1093/glycob/cwm014
   PubMed Web of Science ®Google Scholar
• Ersoy, O., & Kizilay, G. (2018). Effects of fucoidan on diabetic rat testicular tissue. Biotechnic & Histochemistry, 93(4), 277–285. https://doi.org/10.1080/10520295.2018.1434679
   PubMed Web of Science ®Google Scholar
• Gülden, E., Wong, F. S., & Wen, L. (2015). The gut microbiota and type 1 diabetes. Clinical Immunology, 159(2), 143–153. https://doi.org/10.1016/j.clim.2015.05.013
   PubMed Web of Science ®Google Scholar
• Iraha, A., Chinen, H., Hokama, A., Yonashiro, T., Kinjo, T., Kishimoto, K., Nakamoto, M., Hirata, T., Kinjo, N., Higa, F., Tateyama, M., Kinjo, F., & Fujita, J. (2013). Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. World Journal of Gastroenterology, 19(33), 5500–5507. https://doi.org/10.3748/wjg.v19.i33.5500
   PubMed Web of Science ®Google Scholar
• Jain, R., Tartar, D. M., Gregg, R. K., Divekar, R. D., Bell, J. J., Lee, H. H., Yu, P., Ellis, J. S., Hoeman, C. M., Franklin, C. L., & Zaghouani, H. (2008). Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. Journal of Experimental Medicine, 205(1), 207–218. https://doi.org/10.1084/jem.20071878
   PubMed Web of Science ®Google Scholar
• Kiec-Wilk, B., Matejko, B., Razny, U., Stankiewicz, M., Skupien, J., Klupa, T., & Malecki, M. T. (2016). Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus. Atherosclerosis, 251, 334–338. https://doi.org/10.1016/j.atherosclerosis.2016.05.002
   PubMed Web of Science ®Google Scholar
• Kim, K. J., & Lee, B. Y. (2012). Fucoidan from the sporophyll of Undaria pinnatifida suppresses adipocyte differentiation by inhibition of inflammation-related cytokines in 3T3-L1 cells. Nutrition Research, 32(6), 439–447. https://doi.org/10.1016/j.nutres.2012.04.003
   PubMed Web of Science ®Google Scholar
• Kim, K. J., Yoon, K. Y., & Lee, B. Y. (2012). Fucoidan regulate blood glucose homeostasis in C57BL/KSJ m+/+db and C57BL/KSJ db/db mice. Fitoterapia, 83(6), 1105–1109. https://doi.org/10.1016/j.fitote.2012.04.027
   PubMed Web of Science ®Google Scholar
• Klettner, A. (2016). Fucoidan as a potential therapeutic for major blinding diseases–A hypothesis. Marine Drugs, 14(2), https://doi.org/10.3390/md14020031
   PubMed Web of Science ®Google Scholar
• Kumar, S. A., & Brown, L. (2013). Seaweeds as potential therapeutic interventions for the metabolic syndrome. Reviews in Endocrine and Metabolic Disorders, 14(3), 299–308. https://doi.org/10.1007/s11154-013-9254-8
   PubMed Web of Science ®Google Scholar
• Lee, V. H. L. (2000). Membrane transporters. European Journal of Pharmaceutical Sciences, 2, S41–S50. https://doi.org/10.1016/S0928-0987(00)00163-9
   Google Scholar
• Lee, A. S., Gibson, D. L., Zhang, Y., Sham, H. P., Vallance, B. A., & Dutz, J. P. (2010). Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia, 53(4), 741–748. https://doi.org/10.1007/s00125-009-1626-y
   PubMed Web of Science ®Google Scholar
• Li, Y., Liu, Y., & Chu, C. Q. (2015). Th17 cells in type 1 diabetes: Role in the pathogenesis and regulation by gut microbiome. Mediators of Inflammation, 2015, 638470. https://doi.org/10.1155/2015/638470
   PubMed Web of Science ®Google Scholar
• Li, B., Lu, F., Wei, X., & Zhao, R. (2008). Fucoidan: Structure and bioactivity. Molecules, 13(8), 1671–1695. https://doi.org/10.3390/molecules13081671
   PubMed Web of Science ®Google Scholar
• Liang, Z., Zheng, Y., Wang, J., Zhang, Q., Ren, S., Liu, T., Wang, Z., & Luo, D. (2016). Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats. Journal of Ethnopharmacology, 191, 341–349. https://doi.org/10.1016/j.jep.2016.06.054
   PubMed Web of Science ®Google Scholar
• Martel, J., Ojcius, D. M., Chang, C. J., Lin, C. S., Lu, C. C., Ko, Y. F., Tseng, S.-F., Lai, H.-C., & Young, J. D. (2017). Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nature Reviews Endocrinology, 13(3), 149–160. https://doi.org/10.1038/nrendo.2016.142
   PubMed Web of Science ®Google Scholar
• Meddings, J. B., Jarand, J., Urbanski, S. J., Hardin, J., & Gall, D. G. (1999). Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. American Journal of Physiology, 276, 951–957. https://doi.org/10.1152/ajpgi.1999.276.4.g951
   PubMed Web of Science ®Google Scholar
• Mukhamejanov, E., Kon, G., Erjanova, S., & Kirgizbaeva, A. (2019). Fucoidan—new principle prevention and treatment of diabetes. Journal of Pharmacy and Pharmacology, 7, 316–322. https://doi.org/10.17265/2328-2150/2019.06.005
   Google Scholar
• Nagamine, T., Nakazato, K., Tomioka, S., Iha, M., & Nakajima, K. (2014). Intestinal absorption of fucoidan extracted from the brown seaweed, Cladosiphon okamuranus. Marine Drugs, 13(1), 48–64. https://doi.org/10.3390/md13010048
   PubMed Web of Science ®Google Scholar
• Neu, J., Reverte, C. M., Mackey, A. D., Liboni, K., Tuhacek-Tenace, L. M., Hatch, M., Li, N., Caicedo, R. A., Schatz, D. A., & Atkinson, M. (2005). Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. Journal of Pediatric Gastroenterology and Nutrition, 40(5), 589–595. https://doi.org/10.1097/01.MPG.0000159636.19346.C1
   PubMed Web of Science ®Google Scholar
• Opal, S. M., & DePalo, V. A. (2000). Anti-inflammatory cytokines. Chest, 117(4), 1162–1172. https://doi.org/10.1378/chest.117.4.1162
   PubMed Web of Science ®Google Scholar
• Park, J., Cha, J. D., Choi, K. M., Lee, K. Y., Han, K. M., & Jang, Y. S. (2017). Fucoidan inhibits LPS-induced inflammation in vitro and during the acute response in vivo. International Immunopharmacology, 43, 91–98. https://doi.org/10.1016/j.intimp.2016.12.006
   PubMed Web of Science ®Google Scholar
• Park, H. Y., Han, M. H., Park, C., Jin, C. Y., Kim, G. Y., Choi, I. W., Kim, N. D., Nam, T.-J., Kwon, T. K., & Choi, Y. H. (2011). Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. Food and Chemical Toxicology, 49(8), 1745–1752. https://doi.org/10.1016/j.fct.2011.04.020
   PubMed Web of Science ®Google Scholar
• Penny, H. A., Leeds, J. S., Kurien, M., Averginos, A., Hopper, A. D., Hadjivassiliou, M., Tesfaye, S., & Sanders, D. S. (2015). The relationship between inflammatory bowel disease and type 1 diabetes mellitus: A study of relative prevalence in comparison with population controls. Journal of Gastrointestinal and Liver Diseases, 24, 125–126.
   PubMed Web of Science ®Google Scholar
• Raghavendran, H. R., Srinivasan, P., & Rekha, S. (2011). Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. International Immunopharmacology, 11(2), 157–163. https://doi.org/10.1016/j.intimp.2010.11.002
   PubMed Web of Science ®Google Scholar
• Rajapakse, N., & Kim, S. K. (2011). Nutritional and digestive health benefits of seaweed. Advances in Food and Nutrition Research, 64, 17–28. https://doi.org/10.1016/B978-0-12-387669-0.00002-8
   PubMedGoogle Scholar
• Richard, B., Bouton, M. C., Loyau, S., Lavigne, D., Letourneur, D., Jandrot-Perrus, M., & Arocas, V. (2006). Modulation of protease nexin-1 activity by polysaccharides. Thrombosis and Haemostasis, 95(2), 229–235. https://doi.org/10.1160/TH05-08-0546
   PubMed Web of Science ®Google Scholar
• Rocha de Souza, M. C., Marques, C. T., Guerra Dore, C. M., Ferreira da Silva, F. R., Oliveira Rocha, H. A., & Leite, E. L. (2007). Antioxidant activities of sulfated polysaccharides from brown and red seaweeds. Journal of Applied Phycology, 19(2), 153–160. https://doi.org/10.1007/s10811-006-9121-z
   PubMed Web of Science ®Google Scholar
• Sapone, A., de Magistris, L., Pietzak, M., Clemente, M. G., Tripathi, A., Cucca, F., Lampis, R., Kryszak, D., Carteni, M., Generoso, M., Iafusco, D., Prisco, F., Laghi, F., Riegler, G., Carratu, R., Counts, D., & Fasano, A. (2006). Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes, 55(5), 1443–1449. https://doi.org/10.2337/db05-1593
   PubMed Web of Science ®Google Scholar
• Secondulfo, M., Iafusco, D., Carratù, R., deMagistris, L., Sapone, A., Generoso, M., Mezzogiorno, A., Sasso, F. C., Cartenı`, M., De Rosa, R., Prisco, F., & Esposito, V. (2004). Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Digestive and Liver Disease, 36(1), 35–45. https://doi.org/10.1016/j.dld.2003.09.016
   Web of Science ®Google Scholar
• Shi, H., Chang, Y., Gao, Y., Wang, X., Chen, X., Wang, Y., Xue, C., & Tang, Q. (2017). Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide. Food & Function, 8(9), 3383–3393. https://doi.org/10.1039/C7FO00932A
   PubMed Web of Science ®Google Scholar
• Stechova, K., Bohmova, K., Vrabelova, Z., Sepa, A., Stadlerova, G., Zacharovova, K., & Faresjö, M. (2007). High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes/Metabolism Research and Reviews, 23(6), 462–471. https://doi.org/10.1002/dmrr.718
   PubMed Web of Science ®Google Scholar
• Suzuki, T. (2013). Regulation of intestinal epithelial permeability by tight junctions. Cellular and Molecular Life Sciences, 70(4), 631–659. https://doi.org/10.1007/s00018-012-1070-x
   PubMed Web of Science ®Google Scholar
• Vaarala, O. (2011). The gut as a regulator of early inflammation in type 1 diabetes. Current Opinion in Endocrinology, Diabetes and Obesity, 18(4), 241–247. https://doi.org/10.1097/MED.0b013e3283488218
   PubMedGoogle Scholar
• Vaarala, O. (2012). Is the origin of type 1 diabetes in the gut? Immunology and Cell Biology, 90(3), 271–276. https://doi.org/10.1038/icb.2011.115
   PubMed Web of Science ®Google Scholar
• Vaarala, O., Atkinson, M. A., & Neu, J. (2008). The “perfect storm” for type 1 diabetes: The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes, 57(10), 2555–2562. https://doi.org/10.2337/db08-0331
   PubMed Web of Science ®Google Scholar
• Visser, J. T., Lammers, K., Hoogendijk, A., Boer, M. W., Brugman, S., Beijer-Liefers, S., Zandvoort, A., Harmsen, H., Welling, G., Stellaard, F., Bos, N. A., Fasano, A., & Rozing, J. (2010). Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia, 53(12), 2621–2628. https://doi.org/10.1007/s00125-010-1903-9
   PubMed Web of Science ®Google Scholar
• Visser, J., Rozing, J., Sapone, A., Lammers, K., & Fasano, A. (2009). Tight junctions, intestinal permeability, and autoimmunity: Celiac disease and type 1 diabetes paradigms. Annals of the New York Academy of Sciences, 1165(1), 195–205. https://doi.org/10.1111/j.1749-6632.2009.04037.x
   PubMedGoogle Scholar
• Wang, J., Liu, H., Li, N., Zhang, Q., & Zhang, H. (2014). The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy. Marine Drugs, 12(6), 3292–3306. https://doi.org/10.3390/md12063292
   PubMed Web of Science ®Google Scholar
• Wang, X., Yu, H., Shan, A., Jin, Y., Fang, H., Zhao, Y., Shen, J., Zhou, C., Zhou, Y., Fu, Y., Wang, J., & Zhang, J. (2018). Toxic effects of zearalenone on intestinal microflora and intestinal mucosal immunity in mice. Food and Agricultural Immunology, 29(1), 1002–1011. https://doi.org/10.1080/09540105.2018.1503233
   Web of Science ®Google Scholar
• Xue, M., Liang, H., Ji, X., Liu, Y., Ge, Y., Hou, L., & Sun, T. (2019). Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology. Nutrition & Metabolism, 16(1), 87. https://doi.org/10.1186/s12986-019-0392-1
   PubMed Web of Science ®Google Scholar
• Xue, M., Liang, H., Tang, Q., Xue, C., He, X., Zhang, L., & Li, Z. (2017). The protective and immunomodulatory effects of fucoidan against 7,12-dimethyl benz[a]anthracene-induced experimental mammary carcinogenesis through the PD1/PDL1 signaling pathway in rats. Nutrition and Cancer, 69(8), 1234–1244. https://doi.org/10.1080/01635581.2017.1362446
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Chen, S., Zong, X., Wang, C., Shi, C. Y., Wang, F. Q., Wang, Y., & Lu, Z. (2020). Peptides derived from fermented soybean meal suppresses intestinal inflammation and enhances epithelial barrier function in piglets. Food and Agricultural Immunology, 31(1), 120–135. https://doi.org/10.1080/09540105.2019.1705766
   Web of Science ®Google Scholar
• Zhang, Y., & Dong, C. (2007). Regulatory mechanisms of mitogen-activated kinase signaling. Cellular and Molecular Life Sciences, 64(21), 2771–2789. https://doi.org/10.1007/s00018-007-7012-3
   PubMed Web of Science ®Google Scholar
• Zhang, H., Jin, Y., Peng, A., Guo, S., Loor, J., & Wang, H. (2019). L-arginine protects ovine intestinal epithelial cells from lipopolysaccharide-induced intestinal barrier injury. Food and Agricultural Immunology, 30(1), 1067–1084. https://doi.org/10.1080/09540105.2019.1664417
   Web of Science ®Google Scholar
• Zhong, J., Gong, Q., & Mima, A. (2017). Inflammatory regulation in diabetes and metabolic dysfunction. Journal of Diabetes Research, 2017, 5165268. https://doi.org/10.1155/2017/5165268
   PubMed Web of Science ®Google Scholar
• Zhu, Z., Zhang, Q., Chen, L., Ren, S., Xu, P., Tang, Y., & Luo, D. (2010). Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation. Thrombosis Research, 125(5), 419–426. https://doi.org/10.1016/j.thromres.2010.02.011
   PubMed Web of Science ®Google Scholar